PharmaSwiss S.A.
PharmaSwiss S.A., a prominent player in the pharmaceutical industry, is headquartered in Switzerland (CH) and operates extensively across Central and Eastern Europe. Founded in 2004, the company has established itself as a key provider of high-quality generic and specialty pharmaceuticals, focusing on therapeutic areas such as oncology, cardiology, and neurology. With a commitment to innovation and patient care, PharmaSwiss offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a robust distribution network, which have solidified its market position. Recognised for its dedication to quality and compliance, PharmaSwiss continues to make strides in enhancing healthcare outcomes across its operational regions.
DitchCarbon Score
How does PharmaSwiss S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PharmaSwiss S.A.'s score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PharmaSwiss S.A.'s reported carbon emissions
PharmaSwiss S.A., headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. While PharmaSwiss S.A. has not disclosed specific targets or commitments, it is essential for organisations in this sector to align with global climate goals and adopt strategies to mitigate their environmental impact. As the industry evolves, stakeholders will likely expect PharmaSwiss S.A. to establish clear climate commitments and transparency regarding their carbon footprint in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PharmaSwiss S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
